546 related articles for article (PubMed ID: 17014881)
1. Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens.
Smith ML; Corbo T; Bernales J; Lindbo JA; Pogue GP; Palmer KE; McCormick AA
Virology; 2007 Feb; 358(2):321-33. PubMed ID: 17014881
[TBL] [Abstract][Full Text] [Related]
2. Vesicular stomatitis virus glycoprotein: a transducing coat for SFV-based RNA vectors.
Dorange F; Piver E; Bru T; Collin C; Roingeard P; Pagès JC
J Gene Med; 2004 Sep; 6(9):1014-22. PubMed ID: 15352074
[TBL] [Abstract][Full Text] [Related]
3. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response.
Colmenero P; Berglund P; Kambayashi T; Biberfeld P; Liljeström P; Jondal M
Gene Ther; 2001 Sep; 8(17):1307-14. PubMed ID: 11571567
[TBL] [Abstract][Full Text] [Related]
5. Semliki Forest virus-based DNA expression vector: transient protein production followed by cell death.
Kohno A; Emi N; Kasai M; Tanimoto M; Saito H
Gene Ther; 1998 Mar; 5(3):415-8. PubMed ID: 9614563
[TBL] [Abstract][Full Text] [Related]
6. Superior therapeutic efficacy of alphavirus-mediated immunization against human papilloma virus type 16 antigens in a murine tumour model: effects of the route of immunization.
Daemen T; Riezebos-Brilman A; Regts J; Dontje B; van der Zee A; Wilschut J
Antivir Ther; 2004 Oct; 9(5):733-42. PubMed ID: 15535411
[TBL] [Abstract][Full Text] [Related]
7. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
[TBL] [Abstract][Full Text] [Related]
8. Semliki forest virus and Kunjin virus RNA replicons elicit comparable cellular immunity but distinct humoral immunity.
Tannis LL; Gauthier A; Evelegh C; Parsons R; Nyholt D; Khromykh A; Bramson JL
Vaccine; 2005 Jul; 23(33):4189-94. PubMed ID: 16005737
[TBL] [Abstract][Full Text] [Related]
9. In Planta production of immunogenic poliovirus peptide using tobacco mosaic virus-based vector system.
Fujiyama K; Saejung W; Yanagihara I; Nakado J; Misaki R; Honda T; Watanabe Y; Seki T
J Biosci Bioeng; 2006 May; 101(5):398-402. PubMed ID: 16781468
[TBL] [Abstract][Full Text] [Related]
10. Viral vector-based prime-boost immunization regimens: a possible involvement of T-cell competition.
de Mare A; Lambeck AJ; Regts J; van Dam GM; Nijman HW; Snippe H; Wilschut J; Daemen T
Gene Ther; 2008 Mar; 15(6):393-403. PubMed ID: 18004406
[TBL] [Abstract][Full Text] [Related]
11. Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications.
Smith ML; Lindbo JA; Dillard-Telm S; Brosio PM; Lasnik AB; McCormick AA; Nguyen LV; Palmer KE
Virology; 2006 May; 348(2):475-88. PubMed ID: 16466765
[TBL] [Abstract][Full Text] [Related]
12. Coat protein interactions involved in tobacco mosaic tobamovirus cross-protection.
Lu B; Stubbs G; Culver JN
Virology; 1998 Sep; 248(2):188-98. PubMed ID: 9721228
[TBL] [Abstract][Full Text] [Related]
13. Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines.
Withoff S; Glazenburg KL; van Veen ML; Kraak MM; Hospers GA; Störkel S; de Vries EG; Wilschut J; Daemen T
Gene Ther; 2001 Oct; 8(20):1515-23. PubMed ID: 11704811
[TBL] [Abstract][Full Text] [Related]
14. Production of dengue 2 envelope domain III in plant using TMV-based vector system.
Saejung W; Fujiyama K; Takasaki T; Ito M; Hori K; Malasit P; Watanabe Y; Kurane I; Seki T
Vaccine; 2007 Sep; 25(36):6646-54. PubMed ID: 17659815
[TBL] [Abstract][Full Text] [Related]
15. TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models.
McCormick AA; Corbo TA; Wykoff-Clary S; Nguyen LV; Smith ML; Palmer KE; Pogue GP
Vaccine; 2006 Sep; 24(40-41):6414-23. PubMed ID: 16860441
[TBL] [Abstract][Full Text] [Related]
16. Generation of recombinant alphaviral vectors.
Lundstrom K
Cold Spring Harb Protoc; 2012 Jul; 2012(7):825-31. PubMed ID: 22753600
[TBL] [Abstract][Full Text] [Related]
17. Efficient gene delivery into mammalian cells by recombinant baculovirus containing a hybrid cytomegalovirus promoter/Semliki Forest virus replicon.
Pan Y; Zhao Q; Fang L; Luo R; Chen H; Xiao S
J Gene Med; 2009 Nov; 11(11):1030-8. PubMed ID: 19757479
[TBL] [Abstract][Full Text] [Related]
18. Use of surface plasmon resonance imaging to study viral RNA: protein interactions.
Garcia BH; Goodman RM
J Virol Methods; 2008 Jan; 147(1):18-25. PubMed ID: 17875327
[TBL] [Abstract][Full Text] [Related]
19. Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cells.
Zhang J; Asselin-Paturel C; Bex F; Bernard J; Chehimi J; Willems F; Caignard A; Berglund P; Liljeström P; Burny A; Chouaib S
Gene Ther; 1997 Apr; 4(4):367-74. PubMed ID: 9176524
[TBL] [Abstract][Full Text] [Related]
20. Heterologous sequences greatly affect foreign gene expression in tobacco mosaic virus-based vectors.
Shivprasad S; Pogue GP; Lewandowski DJ; Hidalgo J; Donson J; Grill LK; Dawson WO
Virology; 1999 Mar; 255(2):312-23. PubMed ID: 10069957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
